SansRosa Purchased BY CollaGenex
CollaGenex Pharmaceuticals Inc. said it will buy SansRosa Pharmaceutical Development Inc., an assignee of patent applications for the treatment of redness associated with rosacea and other skin disorders.
CollaGenex, a dental and dermatology drug maker, in a news release, said it will pay an initial amount of $750,000 for 51 percent of SansRosa's shares.
The remaining shares will be purchased upon the achievement of various milestones, CollaGenex said.
If the milestones are achieved and a patented product is developed and approved for sale, CollaGenex will pay the shareholders of SansRosa an additional $4 million to $6 million, the company said.
CollaGenex, a dental and dermatology drug maker, in a news release, said it will pay an initial amount of $750,000 for 51 percent of SansRosa's shares.
The remaining shares will be purchased upon the achievement of various milestones, CollaGenex said.
If the milestones are achieved and a patented product is developed and approved for sale, CollaGenex will pay the shareholders of SansRosa an additional $4 million to $6 million, the company said.
posted by Thomas Domingo | 8:34 AM
<< Home